Complete resolution of very late stent thrombosis with systemic thrombolysis

Journal of Cardiovascular Medicine

Volumn 12, Issue 10, 2011, Pages 765-767

  Yiginer, Omer ^a   Kardesoglu, Ejder ^a   Ozmen, Namik ^a   Aparci, Mustafa ^a   Cebeci, Bekir Sitki ^a  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

Author keywords

coronary angiography; myocardial infarction; stents; thrombolytic therapy; thrombosis

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; FIBRINOLYTIC AGENT; HEPARIN; PACLITAXEL; STREPTOKINASE; TISSUE PLASMINOGEN ACTIVATOR;

ACUTE HEART INFARCTION; ADULT; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; DRUG ELUTING STENT; FIBRINOLYTIC THERAPY; GRAFT PATENCY; HEART CATHETERIZATION; HUMAN; MALE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STENT THROMBOSIS; TREATMENT OUTCOME;

ADULT; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CORONARY ANGIOGRAPHY; DRUG-ELUTING STENTS; FIBRINOLYTIC AGENTS; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PACLITAXEL; PROSTHESIS DESIGN; THROMBOLYTIC THERAPY; THROMBOSIS; TIME FACTORS; TREATMENT OUTCOME;

EID: 80052623715     PISSN: 15582027     EISSN: 15582035     Source Type: Journal    
DOI: 10.2459/JCM.0b013e32833cdd5b     Document Type: Article

References (17)

1. Bucalo R, Capranzano P, Conti G, et al. Sirolimus versus paclitaxel-eluting stents in small coronary vessels: long-term outcomes from a single-center registry. J Cardiovasc Med (Hagerstown) 2010; 11:365-368.
2. Valgimigli M, Airoldi F, Zimarino M. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents? J Cardiovasc Med (Hagerstown) 2009; 10 (Suppl 1):S17-S26.
3. Zavalloni D, Bossi P, Rossi ML, Gasparini GL, Lisignoli V, Presbitero P. Inflammatory substrate with eosinophils may be present in bare-metal stent thrombosis. J Cardiovasc Med (Hagerstown) 2009; 10:942-943.
4. D'andrea C, Esposito G, Piscione F, Chiariello M. Tirofiban administration and percutaneous coronary intervention with stenting of saphenous vein graft thrombosis. J Cardiovasc Med (Hagerstown) 2009; 10:875-878.
5. Sardella G, Colantonio R, De Luca L, et al. Comparison between balloon angioplasty and additional coronary stent implantation for the treatment of drug-eluting stent restenosis: 18-month clinical outcomes. J Cardiovasc Med (Hagerstown) 2009; 10:469-473.
6. Cutlip DE, Windecker S, Mehran R, et al. Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007; 115:2344-2351. (Pubitemid 46685903)
7. Iakovou I, Schmidt T, Bonizzoni E, et al. Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents. JAMA 2005; 293:2126-2130. (Pubitemid 40617065)
8. Burzotta F, Parma A, Pristipino C, et al. Angiographic and clinical outcome of invasively managed patients with thrombosed coronary bare metal or drug-eluting stents: the optimist study. Eur Heart J 2008; 29:3011-3021.
9. Daemen J, Wenaweser P, Tsuchida K, et al. Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study. Lancet 2007; 369:667-678. (Pubitemid 46281313)
10. Luscher TF, Steffel J, Eberli FR, et al. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation 2007; 115:1051-1058. (Pubitemid 46328299)
11. De Vita M, Burzotta F, Trani C, et al. Urgent PCI in patients with stent thrombosis: an observational single-center study comparing thrombus aspiration and standard PCI. J Invasive Cardiol 2008; 20:161-165. (Pubitemid 351498683)
12. Koduganti SC, Shankar SJ. Systemic thrombolytic therapy for early coronary stent thrombosis: an observational study. Indian Heart J 2006; 58:245-248.
13. Bowater SE, Doshi SN, Buller NP. Subacute stent thrombosis successfully treated with thrombolysis and glycoprotein IIb/IIIa inhibition. Heart 2005; 91:488. (Pubitemid 40432778)
14. Sciahbasi A, Patrizi R, Madonna M, et al. Successful thrombolysis in patients with subacute and late stent thrombosis. Can J Cardiol 2009; 25:213-214.
15. Karakurt O, Cagirci G, Kilic H, Akdemir R. Resolution of late sirolimuseluting stent thrombosis after tirofiban treatment. Heart Vessels 2009; 24:388-390.
16. Pries AR, Habazettl H, Ambrosio G, et al. A review of methods for assessment of coronary microvascular disease in both clinical and experimental settings. Cardiovasc Res 2008; 80:165-174.
17. Bugiardini R, Badimon L, Collins P, et al. Angina, "normal" coronary angiography, and vascular dysfunction: risk assessment strategies. PLoS Med 2007; 4:e12.